Journal of Clinical Lipidology

Papers
(The H4-Index of Journal of Clinical Lipidology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Cholesterol screening and intervention in youth - It's time to move on92
From the Editors: More Hot Topics in Clinical Lipidology91
From the editor: Hope and strength in community88
Coronary artery calcium scoring in patients with statin associated muscle symptoms: Prescribing statins for those most likely to benefit75
Genetic variants in triglyceride metabolism genes among individuals with hypertriglyceridemia in Colombia52
Monocyte/lymphocyte ratio as a risk factor of cardiovascular and all-cause mortality in coronary artery disease with low-density lipoprotein cholesterol levels below 1.4 mmol/L: A large longitudinal m50
Fibrinogen and plasma clot properties are associated with apolipoprotein B and apolipoprotein B-containing lipoproteins in Africans48
Challenges and opportunities for identifying people with familial hypercholesterolemia in the UK: Evidence from the National FH PASS database46
Impact of cumulative exposure to a high TG to HDL-C ratio on type 2 diabetes risk in young adults45
High-intensity statins vs. moderate-intensity statin-ezetimibe combination therapy: A patient centered approach44
Niacin (Niacin) and clinical utility, don't be misled by recent niacin (Niacin) metabolite report39
Ezetimibe in the management of homozygous familial hypercholesterolaemia39
Comprehensive analysis of Chinese patients with non-LPL familial chylomicronemia syndrome: Genetic variants, dietary interventions, and clinical insights35
The clinical effects of inclisiran, a first-in-class LDL-C lowering siRNA therapy, on the LDL-C levels in Chinese patients with hypercholesterolemia34
Real-world utilization of bempedoic acid in an academic preventive cardiology practice32
Is hypertriglyceridemia a reliable indicator of cholesterol-depleted Apo B particles?29
Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance29
JCL Roundtable. The lipidology team26
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes26
From the editor: A compendium of lipidology progress26
Mysterious Case of Reduction in HDL Cholesterol in a Patient with B-cell Monocytosis26
Genetic Architecture and Cardiovascular Risk of Familial Combined Hyperlipidemia25
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics - Implications for Precision Medicine24
^Sex Disparities in the Treatment and Outcomes of Familial Hypercholesterolemia23
*A Novel ABCG8 Variant and Apo(A) Short Isoform Associated with Premature Atherosclerosis and Familial Hypercholesterolemia Phenocopy.23
0.12548494338989